title: [Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
authors.affiliation: Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Yamada
authors.forename: Masaaki
authors.initials: M
authors.lastname: Inaba
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Nishizawa
mesh_terms: D019386:Alendronate / Q000494:pharmacology / Q000627:therapeutic use*; D016632:Apolipoprotein A-I / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000378:metabolism; D050197:Atherosclerosis / Q000209:etiology* / Q000517:prevention & control*; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000378:metabolism; D006801:Humans; D008798:Mevalonic Acid / Q000378:metabolism; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D016632:Apolipoprotein A-I; D050071:Bone Density Conservation Agents; D008076:Cholesterol, HDL; D008798:Mevalonic Acid; D019386:Alendronate